Anti-PLA2R can be detected in 70–90% of primary MGN patients while anti-THSD7A in 2–3% of anti-PLA2R negative primary MGN patients depending on the technique used. This evidence concerns the gene PLA2R1 and idiopathic membranous glomerulonephritis.